Our research into ovarian cancer

Help us beat cancer sooner


Our life-saving work relies on the money you give us.

Donate now and together we can save more lives by beating cancer sooner.


Donate now

Our research is saving lives

Survival from ovarian cancer has almost doubled over the last 40 years in the UK. We’re proud of the role we’ve played in helping more women survive – from developing the drug carboplatin, to identifying mistakes in genes (including BRCA1 and BRCA2) that increase ovarian cancer risk. Almost half of the women diagnosed with ovarian cancer now survive beyond 5 years, but we know we must do more for the women whose cancers don't respond to treatment.

Rate this page:

Currently rated: 2.7 out of 5 based on 16 votes
Thank you!
We've recently made some changes to the site, tell us what you think